Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Leuk Lymphoma. 2015 Feb 17;56(7):2092–2097. doi: 10.3109/10428194.2014.984703

Table II.

All Drug-Related AEs

Adverse Event Any grade, n (%) Grade 3 or 4, n (%)
Aspartate aminotransferase elevation 11 (78.6) 0
Alanine aminotransferase elevation 10 (71.4) 0
Bilirubin increased 8 (57) 3 (21.4)
Nausea 3 (21.4) 0
Vomiting 2 (14.3) 0
Depressed level of consciousness 1 (7.1) 0
Diarrhea 1 (7.1) 0
Dysphagia 1 (7.1) 1 (7.1)
Dysgeusia 1 (7.1) 0
Exacerbation of COPD 1 (7.1) 0
Elevated alkaline phosphatase 1 (7.1) 0
Hypoaesthesia 1 (7.1) 0
Pollakiuria 1 (7.1) 0

COPD, chronic obstructive pulmonary disease